Surveillance and Oseltamivir Resistance of Human Influenza A Virus in Turkey During the 2007-2008 Season

被引:12
作者
Ciblak, Meral Akcay [1 ]
Hasoksuz, Mustafa [2 ]
Escuret, Vanessa [3 ,4 ]
Valette, Martine [3 ,4 ]
Gul, Fadime [1 ]
Yilmaz, Huseyin [2 ]
Turan, Nuri [2 ]
Bozkaya, Ernel [1 ]
Badur, Selim [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Microbiol & Clin Microbiol, TR-34390 Istanbul, Turkey
[2] Istanbul Univ, Fac Vet, Dept Virol, TR-34390 Istanbul, Turkey
[3] Univ Lyon 1 Virol & Pathol Humaine, Lyon, France
[4] Hosp Civils Lyon, Natl Influenza Ctr S France, Virol Lab, Bron, France
关键词
human influenza A; H1N1; surveillance; oseltamivir resistance; sequencing; Turkey; NEURAMINIDASE INHIBITORS; SENSITIVITY; ZANAMIVIR; STRAINS;
D O I
10.1002/jmv.21546
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Monitoring the activity of influenza viruses is important for establishing the circulating types and for detection of the emergence of novel sub-types and antiviral resistant strains. This is the first report from Turkey on the surveillance and oseltamivir resistance of influenza viruses in 2007-2008. Five hundred twenty-four nasal swabs were tested from different geographical regions in Turkey during November 2007-April 2008. One hundred sixty-three (31%) samples were positive for influenza viruses of which 111 (68%) were influenza A, 52 (31%) influenza B using an immuno-capture ELISA. Forty isolates were selected at random from influenza A positive samples and grown in MDCK cell cultures. The supernatant of the cell cultures was used for RNA extraction followed by RT-PCR to detect the sub-types. Sub-typing revealed all samples as A/H1N1. The N1 gene segment of 30 A/H1N1 samples was sequenced in part, from the 201st to 365th residue, which included the critical region for oseltamivir resistance. Then resulting sequences were analyzed with oseltamivir sensitive and resistant strains obtained from National Center for Biotechnology Information (NCBI) GenBank by CLC Main Workbench Software. H275Y (H274Y according to N2 numbering) mutation, which is known to confer resistance to oseltamivir, was detected in 6 out of 30 (20%) H1N1 isolates from four cities (Istanbul, Bursa, Ankara, and Izmir). The D354G mutation was observed in all oseltamivir resistant H1N1 isolates but not in the oseltamivir sensitive isolates. Assay of neuraminidase activity revealed that these isolates were resistant to oseltamivir, but sensitive to zanamivir. J. Med Virol. 81:1645-1651, 2009. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:1645 / 1651
页数:7
相关论文
共 18 条
[1]   Oseltamivir-Resistant Influenza A Viruses Are Transmitted Efficiently among Guinea Pigs by Direct Contact but Not by Aerosol [J].
Bouvier, Nicole M. ;
Lowen, Anice C. ;
Palese, Peter .
JOURNAL OF VIROLOGY, 2008, 82 (20) :10052-10058
[2]  
Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692
[3]   Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors [J].
Escuret, Vanessa ;
Frobert, Emilie ;
Bouscambert-Duchamp, Maude ;
Sabatier, Murielle ;
Grog, Isidore ;
Valette, Martine ;
Lina, Bruno ;
Morfin, Florence ;
Ferraris, Olivier .
JOURNAL OF CLINICAL VIROLOGY, 2008, 41 (01) :25-28
[4]  
*EUR INFL SURV SCH, 2007, ANN REP 2005 2006 IN
[5]   Sensitivity performed of influenza viruses to zanamivir and oseltamivir: A study on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice [J].
Ferraris, O ;
Kessler, N ;
Lina, B .
ANTIVIRAL RESEARCH, 2005, 68 (01) :43-48
[6]   Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors [J].
Gubareva, LV .
VIRUS RESEARCH, 2004, 103 (1-2) :199-203
[7]   Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets [J].
Herlocher, ML ;
Truscon, R ;
Elias, S ;
Yen, HL ;
Roberts, NA ;
Ohmit, SE ;
Monto, AS .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1627-1630
[8]   The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo [J].
Ives, JAL ;
Carr, JA ;
Mendel, DB ;
Tai, CY ;
Lambkin, R ;
Kelly, L ;
Oxford, JS ;
Hayden, FG ;
Roberts, NA .
ANTIVIRAL RESEARCH, 2002, 55 (02) :307-317
[9]   Influenza pandemics of the 20th century [J].
Kilbourne, ED .
EMERGING INFECTIOUS DISEASES, 2006, 12 (01) :9-14
[10]   Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir [J].
McKimm-Breschkin, J ;
Trivedi, T ;
Hampson, A ;
Hay, A ;
Klimov, A ;
Tashiro, M ;
Hayden, F ;
Zambon, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2264-2272